• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性结直肠肛门恶性肿瘤的病理学特征。

Pathologic Features of Primary Colon, Rectal, and Anal Malignancies.

机构信息

School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Wisconsin State Laboratory of Hygiene, Madison, WI, USA.

出版信息

Cancer Treat Res. 2024;192:233-263. doi: 10.1007/978-3-031-61238-1_12.

DOI:10.1007/978-3-031-61238-1_12
PMID:39212924
Abstract

In USA, colorectal cancer is the third most commonly diagnosed cancer in men, second in women, as well as the third leading cause of cancer deaths (Siegel et al. in Cancer J Clin 73:1-112, 2023 [109]). Worldwide, colorectal cancer is the second leading cause of death and causes almost 916,000 deaths each year (Ferlay in Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, 2020 [28]). Fortunately, due to the colon's surgical and endoscopic accessibility and functional redundancy, colorectal cancer is very treatable. Colonoscopic surveillance has the potential for not only providing tissue for the diagnosis of precancerous polyps and invasive carcinoma, but also preventing development of invasive carcinoma by the removal of precancerous lesions. This chapter discusses the clinical and pathologic features of the spectrum of epithelial, hematolymphoid, and mesenchymal malignant tumors of the colon, rectum, appendix, and anus.

摘要

在美国,结直肠癌是男性中第三大常见癌症,在女性中第二大常见癌症,也是癌症死亡的第三大主要原因(Siegel 等人,Cancer J Clin 73:1-112, 2023 [109])。在全球范围内,结直肠癌是第二大死亡原因,每年导致近 91.6 万人死亡(Ferlay,Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon, 2020 [28])。幸运的是,由于结肠具有手术和内镜可及性以及功能冗余性,结直肠癌非常可治疗。结肠镜检查监测不仅有潜力提供用于诊断癌前息肉和浸润性癌的组织,还可以通过切除癌前病变来预防浸润性癌的发展。本章讨论了结肠、直肠、阑尾和肛门的上皮、血液淋巴和间叶恶性肿瘤的谱的临床和病理特征。

相似文献

1
Pathologic Features of Primary Colon, Rectal, and Anal Malignancies.原发性结直肠肛门恶性肿瘤的病理学特征。
Cancer Treat Res. 2024;192:233-263. doi: 10.1007/978-3-031-61238-1_12.
2
Pathologic Features of Primary Colon, Rectal, and Anal Malignancies.原发性结肠、直肠和肛门恶性肿瘤的病理特征。
Cancer Treat Res. 2016;168:309-30. doi: 10.1007/978-3-319-34244-3_15.
3
[Carcinoma of the anus, rectum and colon].[肛门、直肠和结肠癌]
Med Arh. 2003;57(1 Suppl 2):87-9.
4
Colon, rectum, and anus.结肠、直肠和肛门。
Cancer. 1990 Feb 1;65(3 Suppl):684-8. doi: 10.1002/1097-0142(19900201)65:3+<684::aid-cncr2820651311>3.0.co;2-5.
5
Clinical update: colon, rectal, and anal cancers.临床更新:结肠癌、直肠癌和肛门癌。
Semin Oncol Nurs. 2012 Nov;28(4):e1-22. doi: 10.1016/j.soncn.2012.09.012.
6
General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part II. Histopathological classification. Japanese Research Society for Cancer of the Colon and Rectum.结肠、直肠和肛门癌临床及病理研究通用规则。第二部分。组织病理学分类。日本结肠直肠癌研究学会。
Jpn J Surg. 1983 Nov;13(6):574-98. doi: 10.1007/BF02469506.
7
Carcinoma of the colon, rectum, and anal canal in young patients.年轻患者的结肠癌、直肠癌和肛管癌。
Surg Gynecol Obstet. 1974 Dec;139(6):909-13.
8
Long term outcomes of neuroendocrine carcinomas (high-grade neuroendocrine tumors) of the colon, rectum, and anal canal.结直肠肛门部神经内分泌癌(高级别神经内分泌肿瘤)的长期预后。
J Visc Surg. 2014 Feb;151(1):3-7. doi: 10.1016/j.jviscsurg.2013.12.007. Epub 2014 Jan 8.
9
General rules for clinical and pathological studies on cancer of the colon, rectum and anus. Part I. Clinical classification. Japanese Research Society for Cancer of the Colon and Rectum.结肠、直肠和肛管癌临床及病理研究的一般规则。第一部分。临床分类。日本结肠直肠癌研究学会。
Jpn J Surg. 1983 Nov;13(6):557-73. doi: 10.1007/BF02469505.
10
[Staging of colorectal and anal tumors].[结直肠癌和肛管肿瘤的分期]
Tijdschr Gastroenterol. 1978;21(5):325-40.

引用本文的文献

1
Analysis of cullin family genes in rectal adenocarcinoma: expression, prognostic significance, and therapeutic implications.直肠癌中cullin家族基因的分析:表达、预后意义及治疗启示
Am J Transl Res. 2025 May 15;17(5):3842-3861. doi: 10.62347/UNVS8140. eCollection 2025.

本文引用的文献

1
Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer.超越 RAS 和 BRAF:HER2,晚期结直肠癌的新治疗靶点。
Int J Mol Sci. 2021 Jun 24;22(13):6813. doi: 10.3390/ijms22136813.
2
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status.分析肛门鳞状细胞癌的分子和免疫表型特征,揭示了与 HPV 和 TP53 突变状态相关的不同临床病理分组。
Mod Pathol. 2021 May;34(5):1017-1030. doi: 10.1038/s41379-020-00729-y. Epub 2021 Jan 22.
3
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
错配修复缺陷肿瘤中的程序性死亡受体-1阻断
N Engl J Med. 2015 Jun 25;372(26):2509-20. doi: 10.1056/NEJMoa1500596. Epub 2015 May 30.
4
Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis.罕见部位的胃肠道间质瘤(GISTs):一项基于大样本人群的分析。
J Surg Oncol. 2015 May;111(6):696-701. doi: 10.1002/jso.23873. Epub 2015 Jan 5.
5
PTEN hamartoma tumor syndrome: clinical risk assessment and management protocol.PTEN错构瘤综合征:临床风险评估与管理方案
Methods. 2015 May;77-78:11-9. doi: 10.1016/j.ymeth.2014.10.011. Epub 2014 Oct 22.
6
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.结肠镜息肉切除术与结直肠癌死亡的长期预防。
N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.
7
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms.ENETS关于消化神经内分泌肿瘤患者管理的共识指南:结直肠神经内分泌肿瘤
Neuroendocrinology. 2012;95(2):88-97. doi: 10.1159/000335594.
8
Update on the serrated pathway to colorectal carcinoma.结直肠肿瘤锯齿状途径研究进展。
Hum Pathol. 2011 Jan;42(1):1-10. doi: 10.1016/j.humpath.2010.06.002. Epub 2010 Sep 24.
9
Medullary carcinoma of the large intestine: a population based analysis.大肠髓样癌:一项基于人群的分析。
Int J Oncol. 2010 Oct;37(4):901-7. doi: 10.3892/ijo_00000741.
10
Colorectal lymphoma.结直肠淋巴瘤
Clin Colon Rectal Surg. 2006 May;19(2):49-53. doi: 10.1055/s-2006-942344.